Clinical trials
Observational Carcinoma, Hepatocellular trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
204 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 6 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 8 |
| 2011 | 10 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 9 |
| 2015 | 8 |
| 2016 | 10 |
| 2017 | 12 |
| 2018 | 13 |
| 2019 | 14 |
| 2020 | 17 |
| 2021 | 16 |
| 2022 | 30 |
| 2023 | 21 |
| 2024 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 204 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Taiwan University Hospital | 14 |
| Shanghai Zhongshan Hospital | 11 |
| Sun Yat-sen University | 9 |
| Assiut University | 7 |
| Peking Union Medical College Hospital | 6 |
| Zhongda Hospital | 5 |
| China Medical University Hospital | 4 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 4 |
| Sohag University | 4 |
| Zhejiang University | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 204 |
| Liver Neoplasms | 13 |
| Liver Cirrhosis | 9 |
| Hepatitis B | 7 |
| Fibrosis | 6 |
| Hepatitis B, Chronic | 6 |
| Cholangiocarcinoma | 5 |
| Neoplasms | 5 |
| Neoplastic Cells, Circulating | 5 |
| Recurrence | 5 |
Trials
Showing 1 to 25 of 204. Each trial links to its page on Pharma Observatory.
104 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.